SMTI Projected Dividend Yield

Sanara MedTech Inc ( NASDAQ : SMTI )

Sanara Medtech is a medical technology company. Co.'s products include: CellerateRX Surgical, which is a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds as well as first- and second-degree burns; HYCOL Hydrolyzed Collagen, which is a medical hydrolysate of Type I bovine collagen intended for the management of full and partial thickness wounds including pressure ulcers, venous and arterial leg ulcers and diabetic foot ulcers; and BIAKOS Antimicrobial Skin and Wound Cleanser, which is a product that laboratory tests show disrupts extracellular polymeric substances to eradicate mature biofilm microbes.

20 YEAR PERFORMANCE RESULTS